Covered recipient · General Payments record
ROGER M SIFUENTES
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,051.04
- Reported across 128 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $471.67 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $252.95 | 15 |
| Lilly USA, LLC | $59.31 | 3 |
| Phathom Pharmaceuticals, Inc. | $54.81 | 1 |
| Nevro Corp. | $51.53 | 2 |
| Exact Sciences Corporation | $19.74 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.98 | 1 |
| Averitas Pharma Inc. | $15.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Averitas Pharma Inc. | $15.35 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133446503 | CMS |
| Exact Sciences Corporation | $19.74 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114899033 | CMS |
| Lilly USA, LLC | $17.00 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135400155 | CMS |
| Lilly USA, LLC | $23.26 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135388137 | CMS |
| Lilly USA, LLC | $19.05 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135400157 | CMS |
| Nevro Corp. | $21.85 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130739800 | CMS |
| Nevro Corp. | $29.68 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130739798 | CMS |
| Novo Nordisk Inc | $12.73 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097312383 | CMS |
| Novo Nordisk Inc | $8.46 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096958009 | CMS |
| Novo Nordisk Inc | $12.25 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097796539 | CMS |
| Novo Nordisk Inc | $20.52 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096974713 | CMS |
| Novo Nordisk Inc | $13.70 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097283227 | CMS |
| Novo Nordisk Inc | $21.29 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097014065 | CMS |
| Novo Nordisk Inc | $23.66 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097584280 | CMS |
| Novo Nordisk Inc | $22.50 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096617192 | CMS |
| Novo Nordisk Inc | $21.73 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097740966 | CMS |
| Novo Nordisk Inc | $6.97 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097180852 | CMS |
| Novo Nordisk Inc | $15.90 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096681522 | CMS |
| Novo Nordisk Inc | $21.02 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097209625 | CMS |
| Novo Nordisk Inc | $6.15 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097553521 | CMS |
| Novo Nordisk Inc | $26.74 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096579599 | CMS |
| Novo Nordisk Inc | $19.33 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097237521 | CMS |
| Phathom Pharmaceuticals, Inc. | $54.81 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151126257 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.98 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137676273 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.